Ambry Aiming To Moot Suit Challenging $1B Konica Merger
Attorneys for Ambry Genetics Corp. said late Monday that the diagnostics testing provider will not oppose expedited action on a Chancery Court stockholder challenge to a $1 billion company merger with...To view the full article, register now.
Already a subscriber? Click here to view full article